Average Co-Inventor Count = 3.41
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Actelion Pharmaceuticals Ltd (6 from 217 patents)
2. Idorsia Pharmaceuticals Ltd (3 from 77 patents)
3. Vanda Pharmaceuticals Inc. (1 from 108 patents)
10 patents:
1. 12336980 - Dosing regimen for a selective S1P1 receptor agonist
2. 11834443 - Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
3. 11771683 - Dosing regimen for a selective S1Preceptor agonist
4. 11390615 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenox
5. 10857134 - Dosing regimen for a selective S1Preceptor agonist
6. 10836754 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
7. 10660880 - Dosing regimen for a selective S1Pagonist
8. 10251867 - [object Object]
9. 10220023 - [object Object]
10. 8785484 - Dosing regimen for a selective S1P1 receptor agonist